Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells
Aihong Liang1,2,3† 
Wenmao Zhang1† Qian Wang3† Lan'e Huang1 Jiaming Zhang3 Duo Ma1 Ke Liu1 Shiyu Li1 Xi Chen1 Shan Li1* 
Xiaocan Lei1*- 1Hunan Province Innovative Training Base for Medical Postgraduates, Hengyang Medical School, University of South China and Yueyang Women & Children's Medical Center, Hengyang, Yueyang, Hunan, China
- 2Institute of Reproductive and Stem Cell Engineering, Central South University, Changsha, Hunan, China
- 3Department of Reproductive Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China
Scope: Insulin resistance (IR) has a close relationship with the main clinical manifestations of patients with PCOS; hence, the research and development of new drugs to treat PCOS by improving IR is a desiderate task at present. Resveratrol (RES) possesses a variety of beneficial pharmacological functions, such as antioxidation, anti-inflammatory, regulating glucose, and lipid metabolism. However, whether RES could improve IR and the underlying mechanisms remained unclear in PCOS.
Methods and results: SD rats received a high-fat diet and letrozole for 30 days to establish the PCOS model and then intervened with RES for 30 days. The results demonstrated that RES played a protective role on the IR in PCOS rats, which significantly decreased the levels of blood glucose and serum insulin, up regulated the expression of IGF1R, and down regulated the expression of IGF1. In vitro, KGN cells were treated with insulin, RES, and AGK2, respectively. We found that a high dose of insulin (4μg/mL) significantly inhibited KGN cell viability, decreased the level of lactic acid, and increased the level of pyruvate, while RES (25μM) attenuated the growth-inhibitory effect, as well as increased the level of lactic acid and decreased the level of pyruvate after high levels of insulin treatment. Simultaneously, RES up regulated the expression level of the crucial rate-limiting enzymes relating to glycolytic pathways, such as LDHA, HK2, and PKM2. Furthermore, AGK2 remarkably inhibited the expression level of SIRT2, which was similar to the same negative effects processed by insulin. Meanwhile, RES overtly repaired the glycolysis process by reversing the levels of lactic acid and pyruvate, together with up regulating the expression level of LDHA, HK2, and PKM2, after AGK2 treatment.
Conclusion: RES could effectively improve insulin resistance and restore the glycolysis pathway by regulating SIRT2, which may contribute to attenuating the ovarian damage of PCOS rats and provide a potential treatment for patients with PCOS.
Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder disease in women of childbearing age and affects up to 10%, characterized by hyperandrogenism, sparse ovulation, or anovulation (1). Insulin resistance (IR) and associated compensatory hyperinsulinemia are common features of PCOS affecting 50–70% of women with the disorder (2). IR has been defined as a decreased ability of insulin to regulate the uptake and production of glucose in vivo, which resulted in an increasing amount of insulin to achieve a given metabolic action (3). In the last few decades, numerous studies have identified the ovary as an important target tissue for insulin action (4). Physiological insulin levels promoted the proliferation of granulosa cells, and glucose metabolism of granulosa cells provided energy for the development of oocytes, thereby regulating follicular development (3). By contrast, hyperinsulinemia could promote the apoptosis of ovarian granulosa cells, increase the serum level of androgen, and aggravate hyperandrogenism in patients with PCOS, inhibiting the development of follicles (5–7). In addition, the literature studies have shown that IR could downregulate the expression of PI3K and inhibit PI3K/AKT pathway, reducing the function of insulin to regulate glucose metabolism, causing localized glucose metabolism disorder in the ovary (8, 9). These studies indicated that PCOS follicular dysplasia was closely related to hyperinsulinemia and IR. Meanwhile, multiple lines of evidence have reported that lactate, the main product of glycolysis, plays an important role during folliculogenesis and follicular maturation (10), and the rate of glycolysis was regulated by its rate-limiting enzymes, such as hexokinases (HKs), pyruvate kinase M (PKM), and lactic dehydrogenase (LDH) (11). Our previous research has indicated that abnormal glycolysis, in which the proteins' expression of HK2, PKM2, and LDHA were decreased, was a critical reason for follicular dysplasia in PCOS rats (12). However, the relationship between the IR and the abnormal glycolysis in the PCOS ovary remains ill-defined.
At present, vegetables and fruits rich in natural flavonoid compounds may prevent or delay the onset of diseases such as cardiovascular diseases (13). Resveratrol (3,4,5-trihydroxy-trans-stilbene, RES) is a naturally occurring compound mainly found in dietary plants including the root of polygonum cuspidate, peanut, and grape skin (14, 15). RES has several pharmacological effects including anti-inflammatory, antioxidant, and increased insulin sensitivity (14, 16). Hoseini et al. found that RES significantly decreased the level of insulin and fasting blood glucose in patients with type 2 diabetes complicated with coronary heart disease (17). Furthermore, Zou et al. have revealed that RES ameliorated metabolic disorders and IR in high-fat diet-fed mice (18). In addition, RES also has positive effects on follicular development, such as decreased number of atretic follicles, increased follicular reserve of the ovary, and prolonged ovarian lifespan (19, 20). Meanwhile, RES has a positive effect on improving the architecture of ovarian follicular (21) and suppressing the damage of the ovaries in PCOS rats by restoring glycolytic activity (12). However, the mechanism of RES on IR and the relationship between IR and glycolysis in PCOS remain unclear.
Thus, the present study aimed to examine the effect of RES on ovarian IR in PCOS rats, as well as to explore the mechanisms underlying the IR-regulated glycolysis pathway in PCOS ovarian granulosa cells, which may provide potential strategies for the treatment of PCOS.
Materials and methods
Animals and feeding
All experimental procedures were approved by the Animal Ethics Committee of the University of South China (permit number: USC2020031602). A total of 24 female Sprague-Dawley (SD) rats (5 weeks, 171 ± 11 g) were obtained from the Laboratory Animal Center of the University of South China (Hengyang, China; permit number: SYXK (Xiang) 2020-0002). The rats were raised with free access to food and water in a temperature-controlled room (23 ± 2°C) with a normal dark–light (12 h:12 h) cycle. After 7 days of acclimatization, rats were randomly divided into control (Ctrl) (n = 8) and PCOS (n = 16) groups. The control group received a normal diet, whereas the PCOS group received a high-fat diet (HFD) and letrozole to establish the PCOS model. The experimental group was then randomly divided into a PCOS group (n = 8) and a PCOS-RES group (n = 8), in which rats received oral RES (R8530; Solarbio, China).
Dosage information
In the animal modeling experiment, rats were randomly divided into two groups. Ctrl group: rats were fed a normal diet for 30 days. PCOS group: rats were fed an HFD (consisting of 61.5% ordinary feed, 12% lard, 5% sucrose, 5% milk powder, 5% peanut, 10% egg, 1% sesame oil, and 0.5% salt) and intragastric administration of letrozole [1 mg/kg/d, dissolved in 1% carboxymethyl cellulose (CMC)] for 30 days (22, 23). During the treatment experiment, rats were divided into the Ctrl group, the PCOS group, and the PCOS-RES group. The Ctrl and PCOS rats were fed as described in the modeling experiment for 30 days. The PCOS-RES rats were fed a normal diet and intragastric administration of RES (20 mg/kg/d (24, 25), dissolved in 1% CMC) for 30 days.
Determination of insulin levels
Blood was collected from the abdominal aorta of rats when killed and placed at room temperature (23 ± 2°C) for 30 min before centrifugation at 3,000 rpm for 15 min at 4°C. The level of serum insulin was detected using a radioimmunoassay (Beijing North Institute of Biological Technology, China).
Cell culture and treatment
Human ovarian granulosa-like tumor cell line KGN, which originated from a stage III invasive ovarian granulosa cell carcinoma in a 63-year-old woman, was considered a model for understanding the regulation of steroidogenesis, cell growth, and apoptosis in human granulosa cells (26). In this study, KGN cells were kindly provided by Clinical Anatomy & Reproductive Medicine Application Institute. KGN cells were cultured with Dulbecco's Modified Eagle's Medium-high glucose (DMEM, Sigma, USA) supplemented with 12% fetal bovine serum (FBS, Invitrogen Gibco, USA) and maintained in an atmosphere of 5% CO2 at 37°C.
KGN cells were plated in 6-well plates at 105 per well. After starving for 24 h, the cells were treated without or with insulin (I2643; Sigma, USA) at concentrations of 1, 2, and 4 mg/ml. Then, KGN cells were treated with insulin (4 μg/ml) and RES at concentrations of 10, 25, 50, and 100 μM for 24 h. In addition, the cells were also treated with AGK2 (10 μM, A8231; Sigma, USA) and RES (25 μM) for 24 h.
CCK-8
KGN cells were plated in 96-well plates at 104 per well. After starving for 24 h, the insulin group cells were treated without or with insulin at concentrations of 1, 2, and 4 μg/ml for 24 h. The KGN cells were treated with 4μg/ml of insulin, meanwhile treated with RES at concentrations of 0, 25, 50, and 100 μM for 24 h in the Ins + RES group, and the AGK2 group cells were treated with 10 μM, AGK2+RES were treated with 10 μM AGK2 and 25 μM resveratrol for 24 h. Then CCK-8 was added at 10 μl per well and incubated for 30 min in the incubator, following the manufacturer's protocol. Plates were read on a VersaMax microplate reader at 450 nm wavelength.
Enzyme-Linked Immunosorbent Assay (ELISA)
Lactic acid and pyruvate in the culture supernatant were measured using commercially available ELISA kits. Plates were read on a VersaMax microplate reader at 505 nm (pyruvate) and 530 nm (lactic acid) wavelengths.
Western blot
Ovarian tissues and cultured cells were homogenized in lysates [RIPA lysis buffer (CW2333S; CWBIO, China): PMSF (P0100; Solarbio, China) = 94:6] on ice for 30 min and subsequently centrifuged at 12,000 rpm for 20 min at 4°C. Supernatants were transferred to a clean 1.5 ml tube, and protein concentration was measured by BCA Protein Assay Kit (CW0014; CWBIO, China). Proteins were denatured by boiling at 100°C for 10 min and then separated by 10% SDS-PAGE, electrophoretically transferred onto polyvinylidene fluoride (PVDF) membranes, and blocked in PBST [phosphate-buffered saline (PBS) with 0.1% Tween-20] containing 5% skim milk powder for 2 h. After washing with PBST, the membranes were, respectively, incubated with antibodies against PKM2 (1:1,000, #4053; Cell Signaling Technology, USA), HK2 (1:1000, A0994; ABclonal, China), LDHA (1:1000, #3558; Cell Signaling Technology, USA), SIRT2 (1:1000, A12575; ABclonal, China), and GAPDH (1:1,000, #97166; Cell Signaling Technology, USA) overnight at 4°C. The membranes were further incubated with HRP-conjugated goat anti-mouse or goat anti-rabbit IgG (H+L) (1:5,000, SA00001-1/2; Protein Tech Group Inc., USA) for 2 h at room temperature. Finally, eECL (CW0049M, CWBIO, China) and the Tanon-5500 Chemiluminescence Imaging System were used to detect the chemiluminescence of protein bands.
Quantitative real-time PCR (qPCR)
Total RNA from ovary tissues or KGN cells was extracted using the TRIzol reagent (15596018; Thermo Fisher Scientific, USA). The synthesis of cDNA was performed with the TransScript® One-Step gDNA Removal and cDNA Synthesis SuperMix Kit (AT311-02; TransGen Biotech, China), according to the manufacturer's protocol. Real-time PCR analyses were performed with ChamQ Universal SYBR qPCR Master Mix (Q711-02; Vazyme, China) and Applied Biosystems QuantStudio 3 (Thermo Fisher Scientific, USA). GAPDH was used as the reference, and gene expression levels were calculated using the comparative Ct method (27). The primer sequences used for amplification are shown in Table 1.
Table 1. Primer sequences used for the qRT-PCR analysis.
Statistical analysis
Data were analyzed using GraphPad Prism 8.0 (GraphPad Software, USA) and presented as the mean ± standard deviation. Significant differences within groups were evaluated by the unpaired one-way ANOVA followed by Bonferroni's post-hoc test.
Results
Resveratrol enhanced the ovarian insulin sensitivity in PCOS rats
A PCOS rat model was first established to examine the effects of RES on ovarian insulin sensitivity. As shown in Figures 1A–C, HFD and letrozole treatment remarkably increased the levels of blood glucose, serum insulin, and HOMA-IR compared with that of the Ctrl group (n = 8 each; p < 0.01). The levels of blood glucose and serum insulin were obtained after rats were exposed to PCOS-inducing conditions for 30 days. RES administration significantly reduced the levels of blood glucose, serum insulin, and HOMA-IR of PCOS rats (n = 8 each; p < 0.01) (Figures 1A–C). To explore the effect of RES on ovarian insulin resistance, we detected the expressions of IGF1 and IGF1R. The results of qPCR showed the upregulation of IGF1 and downregulation of IGF1R in PCOS rats, and RES administration significantly restored the mRNA expression of IGF1 and IGF1R (Figures 1D, E). Western blot analysis confirmed the increase of IGF1 and decrease of IGF1R in the PCOS group vs. the Ctrl group, respectively, and the improvement in response to RES treatment (Figures 1F–H). Immunohistochemistry (IHC) analysis confirmed the results, showing an increase of IGF1 and a decrease of IGF1R in the PCOS group and a recovery of values in response to RES treatment (Figure 1I).
Figure 1. Resveratrol can enhance the ovarian insulin sensitivity in PCOS rats. The level of blood glucose (A), serum insulin (B), and HOMA-IR (C) was shown (n = 8). The relative mRNA expression levels of IGF1 (D) and IGF1R (E) in the ovary were determined using qPCR. The protein levels of IGF1 and IGF1R were determined by Western blot (F) and quantified by Image J software [IGF1 (G) and IGF1R (H)]. Immunohistochemistry analysis of the expression of IGF1 and IGF1R (I). Significant differences between the groups are shown as **P < 0.01.
Resveratrol improved the glycolysis process of insulin-treated KNG cells
Then, we deeply explored the mechanism of RES enhancing insulin sensitivity at the cellular level. As shown in Figures 2A–C, we treated KGN cells with different concentrations of insulin and detected the changes in cell viability, and the levels of lactic acid and pyruvic acid. The results of CCK-8 showed 4 μg/ml of insulin decreased KGN cell viability compared with that of the Ctrl group, while there was no significant difference in KGN cells after being treated with 1 and 2 μg/ml of insulin. The results of ELISA showed that with the increase in the concentration of insulin, the level of lactate decreased while pyruvate increased. Thus, we choose the 4 μg/ml insulin for the next experiment. With respect to the concentration of insulin, we added different concentrations of RES to cells. The results showed that 25 and 50 μm of RES could reduce the pyruvate level and increase the lactate level of cells treated with insulin (Figures 2D–F). Lactate has long been proposed to play an important role in follicular development (10); thus, we chose 25 μm of RES, which is the most significant in increasing lactate level for the follow-up experiments.
Figure 2. RES can improve the glycolysis process of insulin-treated KGN cells. Cell viability of KGN cells in which treatment with insulin (A) or insulin and RES (D) was determined using cck-8. The level of lactate in KGN cells, which treated with insulin (B) or insulin and RES (E) using ELISA. The level of pyruvate in KGN cells, which treated with insulin (C) or insulin and RES (F) using ELISA. *ctrl vs. insulin; #insulin vs. insulin + RES. Significant differences between the groups are shown as *P < 0.05, **P < 0.01, #P < 0.05, and ##P < 0.01.
Resveratrol improved the expression of key glycolytic enzymes of insulin-treated KNG cells
The aforementioned experimental results showed that the intervention of RES could enhance the insulin sensitivity of ovarian tissue and promote the process of glycolysis. To explore the effect of insulin resistance on glycolysis, we detected the expression of key glycolytic enzymes (HK2, PKM2, and LDHA) in KGN cells after insulin treatment and RES intervention. The results of qPCR showed the mRNA expressions of HK2, LDHA, and PKM2 were downregulated in KGN cells treated with insulin. RES administration significantly restored the mRNA expression of HK2, LDHA, and PKM2 (Figures 3A–C). Western blot analysis confirmed that insulin decreased the protein expressions of HK2, LDHA, and PKM2 in KGN cells compared with the Ctrl group and the improvement after RES treatment (Figures 3D–G).
Figure 3. RES can improve the expression of key glycolytic enzymes of insulin-treated KGN cells. The relative mRNA expression levels of HK2 (A), LDHA (B), and PKM2 (C) in KGN cells were determined using qPCR. The protein levels of HK2, LDHA, and PKM2 were determined by Western blot (D) and quantified by ImageJ software (E–G). Significant differences between the groups are shown as *P < 0.05 and **P < 0.01.
Resveratrol upregulated the expression of SIRT2 in KGN cells treated with insulin and AGK2
Based on the transcriptome profiling and ovary tissue results in our previous research, we found that SIRT2, an NAD+-dependent deacetylase, was decreased in PCOS rats while increased in PCOS-RES rats (12). In this study, we mainly interrogated the role of SIRT2 in PCOS granulosa cells. First, we detected the mRNA level of SIRT2 in KGN cells treated with insulin and RES, and the results showed that RES could reverse the effect of insulin on SIRT2 (Figure 4A). AGK2 is a specific SIRT2 inhibitor, which is reported to confer neuroprotection (28, 29). To future confirm the effect of RES, we added AGK2 in KGN cells and found that the expression of SIRT2 was significantly downregulated after being treated with AGK2. As expected, RES reversed it (Figure 4B). Meanwhile, Western blot analysis confirmed that the protein expression of SIRT2 was decreased in KGN cells treated with insulin compared with the Ctrl group and increased after RES treatment (Figures 4C–F). To explore the correlation between insulin sensitivity and the glycolysis process in PCOS, we analyzed the correlation between HOMA-IR and key rate-limiting enzymes (HK2, LDHA, and PKM2), glycolytic pathway regulatory factor (SIRT2) and glycolysis products (lactic acid and pyruvate). The results showed that HOMA-IR was negatively correlated with HK2, LDHA, PKM2, SIRT2, and lactic acid levels and had little correlation after RES intervention (Figure 4G), which indicated that RES intervention promoted glycolysis by improving ovarian insulin resistance in PCOS rats.
Figure 4. RES can upregulate the expression of SIRT2 in KGN cells treated with insulin and AGK2. The relative mRNA expression levels of SIRT2 (A, B) in KGN cells were determined using qPCR. The protein level of SIRT2 was determined by Western blot (C, D) and quantified by ImageJ software (E, F). Correlation analysis between insulin sensitivity and glycolysis (G). Significant differences between groups are shown as **P < 0.01.
Resveratrol reversed the inhibitory effect of AGK2 on the process of glycolysis in KGN cells
To find out whether RES regulates glycolysis of granulosa cells through SIRT2, we used qPCR and Western blot to detect the mRNA levels and protein expressions of HK2, PKM2, and LDHA in each group. The results showed that compared with the Ctrl group, the mRNA levels and protein expressions of HK2, PKM2, and LDHA were significantly decreased in KGN cells with AGK2 treatment while significantly increased after RES intervention (Figures 5A–C). Western blot analysis confirmed that the expression of SIRT2 in KGN cells treated with AGK2 was significantly decreased than the Ctrl group and increased after RES treatment (Figures 5D–G). Meanwhile, we detected the levels of lactic acid and pyruvic acid in each group of cells by ELISA to further verify the regulation of SIRT2 on the glycolysis activity of granulosa cells. The results showed that compared with the Ctrl group, AGK2 could significantly reduce the content of lactic acid and increase the accumulation of pyruvate, which significantly improved after RES intervention (Figures 5H, I). This is consistent with the changes in PCOS-like cells constructed by insulin and the levels of glycolysis products in PCOS rats, which further proves that SIRT2 played a key role in RES enhancing insulin sensitivity, improving the glycolysis process of granulosa cells in PCOS rats.
Figure 5. RES can upregulate the expression of SIRT2 in KGN cells treated with insulin and AGK2. The relative mRNA expression levels of HK2 (A), PKM2 (B), and LDHA (C) in KGN cells were determined using qPCR. The protein levels of HK2, LDHA, and PKM2 were determined by Western blot (D) and quantified by ImageJ software (E–G). The levels of lactate and pyruvate in KGN cells using ELISA (H, I). Significant differences between the groups are shown as *P < 0.05 and **P < 0.01.
Discussion
Recently, the increase in the incidence of PCOS has affected the physical and mental health of women of childbearing age, even as young girls (30). RES is under consideration as a new agent for the treatment of PCOS symptoms (21). Our previous study first explored that disorder glycolysis plays an important role in reproductive disorders of PCOS, and RES improves the PCOS rats' follicular development by regulating the glycolytic pathway (12). However, the underlying mechanism of the RES-regulated glycolytic pathway to reverse the reproductive disorders in PCOS is still unclear. Thus, in this study, we investigated the molecular mechanism by which RES improved the follicular development of PCOS. Reports showed that insulin resistance associated with compensatory hyperinsulinemia is a common feature of PCOS affecting 50–70% of women along with ovulation failure (23). Therefore, in this study, we determined the insulin resistance in PCOS rats, the results showed higher levels of glucose and insulin in PCOS rats, and HOMA-IR also increased. Those results were consistent with the study reported by Peng et al. (23), which lays a foundation for subsequent experiments.
A follicle is the basic functional unit of the mammalian ovary, which is structurally divided into oocytes, granulosa cells, and theca cells (31). Studies have shown that IGF is involved in many physiological processes such as follicular growth, steroid synthesis and secretion, follicular atresia, and oocyte maturation, and its expression changes are closely related to insulin resistance (32). It was found that the serum IGF1 level and insulin resistance index (HOMA-IR) of patients with PCOS were significantly increased, and IGF1 was positively correlated with HOMA-IR (33). Similarly, this study found that the expression of IGF1 in the ovarian tissue of PCOS rats was positively correlated with HOMA-IR. Studies have shown that lowering the level of IGF1 effectively improved the serum level of testosterone in PCOS rats and reduced the pathological damage of ovarian tissue (34). The results of this study proved that RES also reduced the expression of IGF1 in ovaries and enhanced insulin sensitivity of ovaries in PCOS rats, which provide a theoretical basis for RES to treat patients with PCOS.
Granulosa cells are the most important somatic cells in the process of follicular development, the change in their morphology and the number is the starting signal of follicular growth and development. As the oocytes lack the glycolytic rate-limiting enzymes, their ability to utilize glucose is rarely low, while granulosa cells have a strong affinity for glucose, transforming glucose into lactic acid, pyruvate, and other substrates, which are essential substances for oocyte growth and development (35, 36). Therefore, the glycolysis rate of granulosa cells is of great significance to the development of follicles and oocytes. Studies have found that the expression of key rate-limiting enzymes of glycolysis: LDHA, HK2, and PKM2 in ovaries of PCOS mice was significantly lower than that of normal mice, and lactic acid production was reduced (37, 38). However, increasing the content of lactic acid in the follicular fluid of patients with PCOS in vitro reduced the occurrence of atresia follicles (39). Lin et al.'s research on the follicular fluid of normal subjects and patients with PCOS showed that the proper amount of insulin could promote the production of lactic acid in the follicular fluid of normal subjects but has no significant effect on the content of lactic acid in the follicular fluid of patients with PCOS (40). In vitro experiments of this subject found that a high dose of insulin inhibited the activity of human ovarian granulosa cells (KGN cells) and reduced the lactic acid content in cells. Similarly, Yan et al. found that insulin resistance could reduce the expression of HK2 in neurons, resulting in the blockage of glycolysis, which confirmed that high levels of insulin could inhibit glycolysis (41). This study confirmed that the HOMA-IR of PCOS rats was negatively correlated with the rate of ovarian glycolysis, and the correlation decreased after the intervention of RES, which further clarified the mechanism of RES in improving follicular development disorder in PCOS rats by enhancing insulin sensitivity and promoting the glycolysis process of granulosa cells.
Studies have shown that RES plays an anti-inflammatory and antioxidant role by activating the expression of Sirtuins in tissues or cells (42). Sirtuins are an NAD+-dependent deacetylase expressed in the whole life system, including SIRT1-7, and SIRT2 mainly exists in the cytoplasm and nucleus, takes key enzymes of glycolysis as targets, and participates in regulating lipid metabolism, glucose metabolism, and oxidative stress (43). Lantier et al. found that knocking out SIRT2 could reduce muscle sensitivity and promote insulin resistance in the liver (44). The results of this study showed that a high dose of insulin in vitro could downregulate the expression of SIRT2 in KGN cells, which indicated that the expression of SIRT2 is also affected by insulin level. In addition, SIRT2 also participated in the regulation of cell glycolysis. Knocking out SIRT2 in an islet could destroy the stability of glucokinase regulatory protein and reduce glycolysis flux (45). AGK2 is a selective SIRT2 inhibitor with an IC50 value of 3.5 μM. Previous studies showed that the addition of AGK2 inhibited SIRT2 activity and rescued the α-Synuclein-mediated toxicity of dorsomedial dopamine neurons (46). Meanwhile, in SIRT2-myc-expressing HeLa cells, AGK2 effectively inhibits the activity of SIRT2 and increases acetylated tubulin (29). In vitro experiments of this subject also proved that SIRT2 activity was inhibited by AGK2 and RES reversed it.
In summary, this topic elaborated the mechanism that RES could enhance the insulin sensitivity of the ovary, promote the glycolysis activity of ovarian granulosa cells, and improve the follicular development disorder of PCOS rats from the animal level and cell level. At the same time, SIRT2 may be the key factor for RES to regulate the rate of glycolysis in ovarian granulosa cells. The research results of this topic further improve the mechanism of PCOS follicular development disorder and provide a new direction and strategy for the clinical prevention and treatment of PCOS diseases.
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.
Ethics statement
The animal study was reviewed and approved by Animal Ethics Committee of the University of South China (permit number: USC2020031602).
Author contributions
XL: conceptualization. AL, LH, JZ, DM, KL, and SL: methodology. XL and ShaL: validation. AL, LH, WZ, QW, XC, SL, and JZ: formal analysis, investigation, and data curation. AL: writing—original draft preparation. AL and XL: writing—reviewing and editing. All authors contributed to the article and approved the submitted version.
Funding
The present study was supported by the Hunan Natural Science Foundation Project (2022JJ30500 and 2022JJ30503), the China National Natural Science Fund (82101720), the Yueyang Maternal and Child Health Hospital Horizontal Cooperation Project (19yyfyhx001), and the National Training Program of Innovation and Entrepreneurship for Undergraduates (S202110555305). Research and Innovation Program for Graduate Students of Hunan Province (CX20210959).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
IR, insulin resistance; PCOS, polycystic ovary syndrome; PCOM, polycystic ovarian morphology; GCs, granulosa cells; RES, resveratrol; Ctrl, control; HFD, high-fat diet; CMC, carboxymethyl cellulose; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum.
References
1. Xiao N, He K, Gong F, Xie Q, Peng J, Su X, et al. Altered subsets and activities of B lymphocytes in polycystic ovary syndrome. J Allergy Clin Immunol. (2019) 143:1943–5.e4. doi: 10.1016/j.jaci.2019.01.007
2. Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. (2012) 77:300–5. doi: 10.1016/j.steroids.2011.12.003
3. Heber MF, Ferreira SR, Abruzzese GA, Raices T, Pignataro OP, Vega M, et al. Metformin improves ovarian insulin signaling alterations caused by fetal programming. J Endocrinol. (2019) 240:431–43. doi: 10.1530/JOE-18-0520
4. Zhao S, Xu H, Cui Y, Wang W, Qin Y, You L, et al. Metabolic actions of insulin in ovarian granulosa cells were unaffected by hyperandrogenism. Endocrine. (2016) 53:823–30. doi: 10.1007/s12020-016-0949-y
5. Coutinho EA, Kauffman AS. The role of the brain in the pathogenesis and physiology of polycystic ovary syndrome (PCOS). Med Sci. (2019) 7:84. doi: 10.3390/medsci7080084
6. Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. (2017) 40:1–8. doi: 10.1007/s40618-016-0523-8
7. Wang C, Ding C, Hua Z, Chen C, Yu J. Cangfudaotan decoction alleviates insulin resistance and improves follicular development in rats with polycystic ovary syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 pathway. Mediat Inflamm. (2020) 2020:8865647. doi: 10.1155/2020/8865647
8. Anjali G, Kaur S, Lakra R, Taneja J, Kalsey GS, Nagendra A, et al. FSH stimulates IRS-2 expression in human granulosa cells through cAMP/SP1, an inoperative FSH action in PCOS patients. Cell Signall. (2015) 27:2452–66. doi: 10.1016/j.cellsig.2015.09.011
9. Belani M, Deo A, Shah P, Banker M, Singal P, Gupta S. Differential insulin and steroidogenic signaling in insulin resistant and non-insulin resistant human luteinized granulosa cells—a study in PCOS patients. J Steroid Biochem Mol Biol. (2018) 178:283–92. doi: 10.1016/j.jsbmb.2018.01.008
10. Fontana J, Martínková S, Petr J, Žalmanová T, Trnka J. Metabolic cooperation in the ovarian follicle. Physiol Res. (2020) 19:33–48. doi: 10.33549/physiolres.934233
11. Xiong Y, Lei QY, Zhao S, Guan KL. Regulation of glycolysis and gluconeogenesis by acetylation of PKM and PEPCK. Cold Spring Harbor Symposia Quantit Biol. (2011) 76:285–9. doi: 10.1101/sqb.2011.76.010942
12. Liang A, Huang L, Liu H, He W, Lei X, Li M, et al. Resveratrol improves follicular development of PCOS rats by regulating the glycolytic pathway. Mol Nutr Food Res. (2021) 65:e2100457. doi: 10.1002/mnfr.202100457
13. Wang L, Zhao H, Wang L, Tao Y, Du G, Guan W, et al. Effects of selected resveratrol analogues on activation and polarization of lipopolysaccharide-stimulated BV-2 microglial cells. J Agric Food Chem. (2020) 68:3750–7. doi: 10.1021/acs.jafc.0c00498
14. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. (2006) 5:493–506. doi: 10.1038/nrd2060
15. Ashkar F, Eftekhari MH, Tanideh N, Koohpeyma F, Mokhtari M, Irajie C, et al. Effect of hydroalcoholic extract of Berberis integerrima and resveratrol on ovarian morphology and biochemical parameters in Letrozole-induced polycystic ovary syndrome rat model: an experimental study. Int J Reprod Biomed. (2020) 18:637–50. doi: 10.18502/ijrm.v13i8.7505
16. Piras AR, Ariu F, Falchi L, Zedda MT, Pau S, Schianchi E, et al. Resveratrol treatment during maturation enhances developmental competence of oocytes after prolonged ovary storage at 4 degrees C in the domestic cat model. Theriogenology. (2020) 144:152–7. doi: 10.1016/j.theriogenology.2020.01.009
17. Hoseini A, Namazi G, Farrokhian A, Reiner Ž, Aghadavod E, Bahmani F, et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct. (2019) 10:6042–51. doi: 10.1039/C9FO01075K
18. Gong L, Guo S, Zou Z. Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice. Life Sci. (2020) 242:117212. doi: 10.1016/j.lfs.2019.117212
19. Chen Z-G, Luo L-L, Xu J-J, Zhuang X-L, Kong X-X, Fu Y-C. Effects of plant polyphenols on ovarian follicular reserve in aging rats. Biochem Cell Biol. (2010) 88:737–45. doi: 10.1139/O10-012
20. Banu SK, Stanley JA, Sivakumar KK, Arosh JA, Burghardt RC. Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol. Toxicol Appl Pharmacol. (2016) 303:65–78. doi: 10.1016/j.taap.2016.04.016
21. Rencber SF, Ozbek SK, Eraldemir C, Sezer Z, Kum T, Ceylan S, et al. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study. J Ovarian Res. (2018) 11:55. doi: 10.1186/s13048-018-0427-7
22. Yun C, Xin X. Experimental study on establishmaent of rat model of polycystic ovary syndrome with insulin resistance by letrozole combined with high fat diet. J Capital Med Univ. (2017) 38:244–8. doi: 10.3969/j.issn.1006-7795.2017.02.018
23. Peng M-F, Tian S, Song Y-G, Li C-X, Miao M-S, Ren Z, et al. Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol. (2021) 273:113947. doi: 10.1016/j.jep.2021.113947
24. Yazir Y, Utkan T, Gacar N, Aricioglu F. Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress. Physiol Behav. (2015) 138:297–304. doi: 10.1016/j.physbeh.2014.10.010
25. Vega CC, Reyes-Castro LA, Rodríguez-González GL, Bautista CJ, Vázquez-Martínez M, Larrea F, et al. Resveratrol partially prevents oxidative stress and metabolic dysfunction in pregnant rats fed a low protein diet and their offspring. J Physiol. (2016) 594:1483–99. doi: 10.1113/JP271543
26. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, Saito M, et al. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology. (2001) 142:1. doi: 10.1210/endo.142.1.7862
27. Al-Sabah A, Stadnik P, Gilbert SJ, Duance VC, Blain EJ. Importance of reference gene selection for articular cartilage mechanobiology studies. Osteoarthr Cartil. (2016) 24:719–30. doi: 10.1016/j.joca.2015.11.007
28. Villalba JM, Alcaín FJ. Sirtuin activators and inhibitors. Biofactors. (2012) 38:349–59. doi: 10.1002/biof.1032
29. Bai X, Yao L, Ma X, Xu X. Small molecules as SIRT modulators. Mini Rev Med Chem. (2016) 16:1151–7. doi: 10.2174/1389557516666160620095103
30. Gnawali A, Patel V, Cuello-Ramírez A, Kaabi ASA, Noor A, Rashid MY, et al. Why are women with polycystic ovary syndrome at increased risk of depression? exploring the etiological maze. Cureus. (2021) 13:e13489. doi: 10.7759/cureus.13489
31. Knight PG, Glister C. Potential local regulatory functions of inhibins, activins and follistatin in the ovary. Reproduction. (2001) 121:503–12. doi: 10.1530/rep.0.1210503
32. Kwintkiewicz J, Giudice LC. The interplay of insulin-like growth factors, gonadotropins, and endocrine disruptors in ovarian follicular development and function. Semin Reprod Med. (2009) 27:43–51. doi: 10.1055/s-0028-1108009
33. Kebapcilar AG, Tatar MG, Ipekci SH, Gonulalan G, Korkmaz H, Baldane S, et al. Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance. Arch Gynecol Obstetr. (2014) 290:1255–63. doi: 10.1007/s00404-014-3353-y
34. Zhen J, Li J, Li X, Wang X, Xiao Y, Sun Z, Yu Q. Downregulating lncRNA NEAT1 induces proliferation and represses apoptosis of ovarian granulosa cells in polycystic ovary syndrome via microRNA-381/IGF1 axis. J Biomed Sci. (2021) 28:53. doi: 10.1186/s12929-021-00749-z
35. Wen J, Wang G-L, Yuan H-J, Zhang J, Xie H-L, Gong S, et al. Effects of glucose metabolism pathways on nuclear and cytoplasmic maturation of pig oocytes. Sci Rep. (2020) 10:2782. doi: 10.1038/s41598-020-59709-6
36. Jiang X, Pang Y, Zhao S, Hao H, Zhao X, Du W, et al. Thioredoxin-interacting protein regulates glucose metabolism and improves the intracellular redox state in bovine oocytes during in vitro maturation. Am J Physiol Endocrinol Metab. (2020) 318:E405–16. doi: 10.1152/ajpendo.00057.2019
37. Zhang S, Tu H, Yao J, Le J, Jiang Z, Tang Q, et al. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway. Reprod Biol Endocrinol. (2020) 18:58. doi: 10.1186/s12958-020-00613-z
38. Huang L, Liang A, Li T, Lei X, Chen X, Liao B, et al. Mogroside V improves follicular development and ovulation in young-adult PCOS rats induced by letrozole and high-fat diet through promoting glycolysis. Front Endocrinol. (2022) 13:838204. doi: 10.3389/fendo.2022.838204
39. Kollmann Z, Schneider S, Fux M, Bersinger NA, von Wolff M. Gonadotrophin stimulation in IVF alters the immune cell profile in follicular fluid and the cytokine concentrations in follicular fluid and serum. Hum Reprod. (2017) 32:820–31. doi: 10.1093/humrep/dex005
40. Lin Y, Fridström M, Hillensjö T. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells: a comparison between normal and polycystic ovaries. Hum Reprod. (1997) 12:2469–72. doi: 10.1093/humrep/12.11.2469
41. Chow HM, Shi M, Cheng A, Gao Y, Chen G, Song X, et al. Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence. Nat Neurosci. (2019) 22:1806–19. doi: 10.1038/s41593-019-0505-1
42. Cong L, Lei M-Y, Liu Z-Q, Liu Z-F, Ma Z, Liu K, et al. Resveratrol attenuates manganese-induced oxidative stress and neuroinflammation through SIRT1 signaling in mice. Food Chem Toxicol. (2021) 153:112283. doi: 10.1016/j.fct.2021.112283
43. Hamaidi I, Zhang L, Kim N, Wang M-H, Iclozan C, Fang B, et al. Sirt2 inhibition enhances metabolic fitness and effector functions of tumor-reactive T cells. Cell Metab. (2020) 32:420–36.e12. doi: 10.1016/j.cmet.2020.07.008
44. Lantier L, Williams AS, Hughey CC, Bracy DP, James FD, Ansari MA, et al. SIRT2 knockout exacerbates insulin resistance in high fat-fed mice. PLoS ONE. (2018) 13:e0208634. doi: 10.1371/journal.pone.0208634
45. Zhou F, Zhang L, Zhu K, Bai M, Zhang Y, Zhu Q, et al. SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux. Theranostics. (2021) 11:4825–38. doi: 10.7150/thno.55330
Keywords: resveratrol, PCOS, insulin resistance, SIRT2, glycolysis
Citation: Liang A, Zhang W, Wang Q, Huang L, Zhang J, Ma D, Liu K, Li S, Chen X, Li S and Lei X (2023) Resveratrol regulates insulin resistance to improve the glycolytic pathway by activating SIRT2 in PCOS granulosa cells. Front. Nutr. 9:1019562. doi: 10.3389/fnut.2022.1019562
Received: 15 August 2022; Accepted: 23 December 2022;
Published: 18 January 2023.
Edited by:
Ana Vinha, Fernando Pessoa University, PortugalReviewed by:
Arnab Banerjee, Birla Institute of Technology and Science, IndiaBernard Fioretti, University of Perugia, Italy
Copyright © 2023 Liang, Zhang, Wang, Huang, Zhang, Ma, Liu, Li, Chen, Li and Lei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaocan Lei, 
liulincun@163.com; Shan Li, 791816918@qq.com
†These authors have contributed equally to this work